Why the study?
Does combination therapy with cariporide, regional hypothermia, and ischemic preconditioning reduce myocardial infarct size in a rabbit model of coronary artery occlusion?
Does combination therapy with cariporide, regional hypothermia, and ischemic preconditioning reduce myocardial infarct size in a rabbit model of coronary artery occlusion?
Answers are grounded in this paper and cite their sources.
A combination of cariporide, ischemic preconditioning, and regional hypothermia dramatically reduces myocardial infarct size in a rabbit model of ischemia/reperfusion.
The aim of this study was to test whether myocardial infarct size reduction would be optimized by combining three known effective therapies: cariporide, regional hypothermia, and ischemic preconditioning (CHIP). Before coronary artery occlusion (CAO), treated rabbits (CHIP, n = 7) received cariporide (0.3 mg/kg), ischemic preconditioning (7 minutes ischemia and 5 minutes reperfusion), then 20 minutes of mild regional hypothermia (34 degrees C). Control rabbits (n = 7) received saline and a 34-minute waiting period. All received 30 minutes of CAO and reperfusion. In another study, rabbits (n = 8 in each group) received 90 minutes of CAO. In the 30-minute protocol, the authors found that hearts in both groups were equally ischemic during CAO. Mean ischemic risk zones were similar in both groups; however, in CHIP hearts, infarct size was 4 +/- 1% of risk zone, a reduction of 91% compared with control rabbits (44 +/- 7% of the risk zone, P = 0.001). In the 90-minute protocol, risk zone size was similar in both groups, but infarct size in control hearts was 76 +/- 3% of the risk zone compared with 34 +/- 7% in CHIP treated hearts (P = 0.0003). In summary, the combined treatment provided extraordinary protection. Infarct comprised only 4% of the risk region after 30-minute ischemia-a far greater reduction than was previously observed in the same laboratory using any single intervention. After 90 minutes of ischemia, infarct was 55% lower in CHIP hearts, suggesting that this therapeutic approach dramatically reduces ischemia/reperfusion cell death, even during long occlusions.
No takes yet. Share an insight, caveat, or question.
Hale et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: